# Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir

> **NCT01694706** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** faldaprevir
- **DRUG:** faldaprevir
- **DRUG:** omeprazole
- **DRUG:** faldaprevir

## Key facts

- **NCT ID:** NCT01694706
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694706, "Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01694706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
